BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15571097)

  • 21. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
    Philip J; Hanchanale V; Foster CS; Javlé P
    BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of extended pattern technique for initial prostate biopsy.
    Siu W; Dunn RL; Shah RB; Wei JT
    J Urol; 2005 Aug; 174(2):505-9. PubMed ID: 16006881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of extracapsular extension of prostate cancer based on systematic core biopsies.
    Tarján M; Tot T
    Scand J Urol Nephrol; 2006; 40(6):459-64. PubMed ID: 17130097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are repeat biopsies required in men with PSA levels < or =4 ng/ml? A Multiinstitutional Prospective European Study.
    Djavan B; Fong YK; Ravery V; Remzi M; Horninger W; Susani M; Kreuzer S; Boccon-Gibod L; Bartsch G; Marberger M
    Eur Urol; 2005 Jan; 47(1):38-44; discussion 44. PubMed ID: 15582247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
    Anastasiadis AG; Lichy MP; Nagele U; Kuczyk MA; Merseburger AS; Hennenlotter J; Corvin S; Sievert KD; Claussen CD; Stenzl A; Schlemmer HP
    Eur Urol; 2006 Oct; 50(4):738-48; discussion 748-9. PubMed ID: 16630688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of cancers detected at only a sextant or alternative location.
    Ochiai A; Troncoso P; Babaian RJ
    BJU Int; 2008 Apr; 101(7):837-40. PubMed ID: 18070187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualized prostate biopsy strategy for Chinese patients with different prostate-specific antigen levels.
    Dai B; Ye DW; Kong YY; Shen YJ; Wang BH
    Asian J Androl; 2008 Mar; 10(2):325-31. PubMed ID: 18097514
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extended 12-core prostate biopsy increases both the detection of prostate cancer and the accuracy of Gleason score.
    Elabbady AA; Khedr MM
    Eur Urol; 2006 Jan; 49(1):49-53; discussion 53. PubMed ID: 16314035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Analysis of transrectal needle biopsy of the prostate: usefulness of systematic 12 core biopsy].
    Imazu T; Yokoyama S; Fukuhara S; Hara T; Yamaguchi S; Adachi S
    Hinyokika Kiyo; 2007 Jun; 53(6):365-8. PubMed ID: 17628932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of transperineal six-core prostate biopsy in patients with prostate-specific antigen level greater than 10 ng/mL and abnormal digital rectal examination findings.
    Luciani LG; De Giorgi G; Valotto C; Zanin M; Bierti S; Zattoni F
    Urology; 2006 Mar; 67(3):555-8. PubMed ID: 16527579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The independent impact of extended pattern biopsy on prostate cancer stage migration.
    Master VA; Chi T; Simko JP; Weinberg V; Carroll PR
    J Urol; 2005 Nov; 174(5):1789-93; discussion 1793. PubMed ID: 16217288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A prospective randomised trial of extended core prostate biopsy protocols utilizing 12 versus 15 cores.
    Rochester MA; Griffin S; Chappell B; McLoughlin J
    Urol Int; 2009; 83(2):155-9. PubMed ID: 19752609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The electromagnetic detection of prostatic cancer: evaluation of diagnostic accuracy.
    Tubaro A; De Nunzio C; Trucchi A; Stoppacciaro A; Miano L
    Urology; 2008 Aug; 72(2):340-4. PubMed ID: 18336888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increasing the number of biopsy cores improves the concordance of biopsy Gleason score to prostatectomy Gleason score.
    Coogan CL; Latchamsetty KC; Greenfield J; Corman JM; Lynch B; Porter CR
    BJU Int; 2005 Aug; 96(3):324-7. PubMed ID: 16042723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histological diagnosis of prostate cancer in Korean men aged 70-79 years.
    Shim HB; Lee SE; Park HK; Ku JH
    Jpn J Clin Oncol; 2007 Oct; 37(10):782-7. PubMed ID: 17913831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is it necessary to detect all prostate cancers in men with serum PSA levels <3.0 ng/ml? A comparison of biopsy results of PCPT and outcome-related information from ERSPC.
    Schröder FH; Bangma CH; Roobol MJ
    Eur Urol; 2008 May; 53(5):901-8. PubMed ID: 18262712
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in patterns of practice in diagnosing screen-detected prostate cancer.
    Nam RK; Toi A; Trachtenberg J; Jewett MA; Klotz L; Fleshner N; Bagnell PS; Sweet J; Sugar L; Narod SA
    BJU Int; 2004 Dec; 94(9):1239-44. PubMed ID: 15610097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol.
    Ghani KR; Dundas D; Patel U
    BJU Int; 2004 Nov; 94(7):1014-20. PubMed ID: 15541119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
    Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
    BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men.
    Postma R; Schröder FH; van der Kwast TH
    Urology; 2005 Apr; 65(4):745-9. PubMed ID: 15833520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.